newsfilter
← Latest News
Business Wire·

Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2022

Earnings Call with Management Team Scheduled for Today at 9:00am EST Summit Therapeutics Inc. (NASDAQ:SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an